TORONTO, April 25 /PRNewswire-FirstCall/ - MDS Inc. , a global company providing a range of enabling products and services to the global life sciences markets, announced that Stephen DeFalco, President and Chief Executive Officer, will present at the Scotia Capital Pharmaceutical & Biotechnology Conference on Wednesday, April 26th at 11:40 am (ET).
Interested parties may access the live webcast by visiting the “Latest News” section of the homepage at www.mdsinc.com. An audio archive of the presentation will be available under Webcasts & Presentations in our “For Investors” section until May 26, 2006.
MDS Inc. has more than 8,800 highly skilled people in 27 countries. We provide a diverse range of superior products and services to increase our customers’ speed, precision and productivity in the drug development and disease diagnosis processes. We are a global, values-driven life sciences company, recognized for our reliability and collaborative relationships as we help create better outcomes in the treatment of disease. Find out more at www.mdsinc.com or by calling 1-800-MDS-7222, 24 hours a day.
MDS Inc.
CONTACT: Sharon Mathers, Vice-President, Investor Relations and ExternalCommunications, (416) 675-6777 x 4721, Sharon.Mathers@mdsinc.com
